| Issue Date | Title | Author(s) |
| 2018-06-28 | Melanoma circulating tumor cells: Benefits and challenges required for clinical application | Marsavela, G; Aya-Bonilla, CA; Warkiani, ME; Gray, ES; Ziman, M |
| 2015-06-20 | Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy. | Khoo, BL; Lee, SC; Kumar, P; Tan, TZ; Warkiani, ME; Ow, SGW; Nandi, S; Lim, CT; Thiery, JP |
| 2021-11-06 | Affibody Functionalized Beads for the Highly Sensitive Detection of Cancer Cell-Derived Exosomes | Sayyadi, N; Zhand, S; Razavi Bazaz, S; Warkiani, ME |
| 2022-12-15 | DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine. | Fatemi, N; Tierling, S; Es, HA; Varkiani, M; Mojarad, EN; Aghdaei, HA; Walter, J; Totonchi, M |
| 2021-08 | Machine learning and network-based models to identify genetic risk factors to the progression and survival of colorectal cancer. | Hossain, MJ; Chowdhury, UN; Islam, MB; Uddin, S; Ahmed, MB; Quinn, JMW; Moni, MA |
| 2014-12-08 | Rule discovery and distance separation to detect reliable miRNA biomarkers for the diagnosis of lung squamous cell carcinoma | Song, R; Liu, Q; Hutvagner, G; Nguyen, H; Ramamohanarao, K; Wong, L; Li, J |
| 2020-04 | MAML1 promotes ESCC aggressiveness through upregulation of EMT marker TWIST1. | Forghanifard, MM; Azaraz, S; Ardalan Khales, S; Morshedi Rad, D; Abbaszadegan, MR |
| 2015-01-01 | A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer | Jiang, R; Lu, YT; Ho, H; Li, B; Chen, JF; Lin, M; Li, F; Wu, K; Wu, H; Lichterman, J; Wan, H; Lu, CL; OuYang, W; Ni, M; Wang, L; Li, G; Lee, T; Zhang, X; Yang, J; Rettig, M; Chung, LWK; Yang, H; Li, KC; Hou, Y; Tseng, HR; Hou, S; Xu, X; Wang, J; Posadas, EM |
| 2021 | Emerging role of circulating tumor cells in immunotherapy. | Rzhevskiy, A; Kapitannikova, A; Malinina, P; Volovetsky, A; Aboulkheyr Es, H; Kulasinghe, A; Thiery, JP; Maslennikova, A; Zvyagin, AV; Ebrahimi Warkiani, M |
| 2022-08 | Application of circulating tumour cells to predict response to treatment in head and neck cancer. | Zhang, X; Ekanayake Weeramange, C; Hughes, BGM; Vasani, S; Liu, ZY; Warkiani, ME; Hartel, G; Ladwa, R; Thiery, JP; Kenny, L; Punyadeera, C |
